BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33220975)

  • 21. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
    Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
    Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
    Machado MC
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):145-8. PubMed ID: 22584720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
    Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
    ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
    Haynes AB; Deshpande V; Ingkakul T; Vagefi PA; Szymonifka J; Thayer SP; Ferrone CR; Wargo JA; Warshaw AL; Fernández-del Castillo C
    Arch Surg; 2011 May; 146(5):534-8. PubMed ID: 21576607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
    Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
    Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
    Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.
    Herrera MF; Åkerström G; Angelos P; Grant CS; Hoff AO; Pantoja JP; Pérez-Johnston R; Sahani DV; Wong RJ; Randolph G
    Endocr Pract; 2015 May; 21(5):546-53. PubMed ID: 25962093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
    Nell S; Verkooijen HM; Pieterman CRC; de Herder WW; Hermus AR; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Ann Surg; 2018 Jun; 267(6):1155-1160. PubMed ID: 28257328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections.
    Crippa S; Zerbi A; Boninsegna L; Capitanio V; Partelli S; Balzano G; Pederzoli P; Di Carlo V; Falconi M
    Arch Surg; 2012 Mar; 147(3):261-6. PubMed ID: 22430908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to follow up and when to operate asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1?
    Tonelli F
    J Clin Gastroenterol; 2014; 48(5):387-9. PubMed ID: 24714102
    [No Abstract]   [Full Text] [Related]  

  • 35. Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
    Lopez CL; Albers MB; Bollmann C; Manoharan J; Waldmann J; Fendrich V; Bartsch DK
    World J Surg; 2016 Jul; 40(7):1729-36. PubMed ID: 26956903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
    Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
    Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
    Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
    Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.